RecruitingNot ApplicableNCT06224205

Digital Detection of Dementia (D Cubed) Studies: D3


Sponsor

Indiana University

Enrollment

3,150 participants

Start Date

Nov 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.


Eligibility

Min Age: 65 Years

Inclusion Criteria5

  • years or older
  • At least one visit to primary care practice within the past year
  • Ability to provide informed consent
  • Ability to communicate in English or Spanish
  • Available EHR data from at least the past three years

Exclusion Criteria4

  • Prior ADRD or mild cognitive impairment diagnosis as determined by ICD-10 code
  • Evidence of any history of prescription for a cholinesterase inhibitors or memantine.
  • Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code
  • Permanent resident of a nursing facility

Interventions

OTHERPassive Digital Marker for screening for ADRD

Patients in the primary care clinics randomized to PDM+QDRS will have Electronic Health Record Data of their patients run through the PDM, a machine learning algorithm which can predict ADRD one year and three years prior to its onset. In addition, patients from these clinics will have their patients complete the QDRS, a validated patient reported outcome (PRO) tool. This combined approach will assess the value of early detection of ADRD and if the annual well visit can overcome the barriers related to early detection of ADRD.


Locations(1)

University of Miami School of Medicine

Boca Raton, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06224205


Related Trials